<DOC>
	<DOC>NCT00504309</DOC>
	<brief_summary>The purpose of this study is to evaluate the cardiovascular and lipid effects of two doses of an omega-3 fatty acid concentrate in a group of people who normally are not treated for high lipids.</brief_summary>
	<brief_title>Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>triglycerides 150500 mg/dL aged 2165 generally healthy BMI 2039 smoking premenopausal (if female) use of hormone replacement or oral contraceptives use of lipid lowering or blood pressure medication hypertension (BP &gt; 150/95) peripheral vascular disease heart disease, diabetes, or stroke inflammatory disease (e.g. rheumatoid arthritis or crohn's) elevated liver enzymes high intake of omega3 containing foods allergy to adhesive or latex use of aspirin, anticoagulants, or SSRI</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>triglycerides</keyword>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>omega-3</keyword>
	<keyword>n-3</keyword>
	<keyword>eicosapentaenoic acid</keyword>
	<keyword>EPA</keyword>
	<keyword>docosahexaenoic acid</keyword>
	<keyword>DHA</keyword>
	<keyword>flow mediated dilation</keyword>
	<keyword>fish</keyword>
	<keyword>Moderate hypertriglyceridemia</keyword>
</DOC>